ClinicalTrials.Veeva

Menu

Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes

S

Solvay

Status

Completed

Conditions

Hypertension
Type 2 Diabetes

Treatments

Drug: eprosartan/HCTZ

Study type

Interventional

Funder types

Industry

Identifiers

NCT00160160
S171.3.012
2004-00703-18

Details and patient eligibility

About

This study is to demonstrate the superiority of combination of eprosartan/HCTZ versus ramipril/HCTZ.

Sex

All

Ages

40 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • essential hypertension,
  • diabetes type 2

Exclusion criteria

  • severe cardiovascular disease,
  • grade 3 hypertension,
  • secondary hypertension,
  • abnormal liver enzymes

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

63

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems